<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Can J Anaesth</journal-id>
      <journal-title-group>
        <journal-title>Canadian Journal of Anaesthesia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0832-610X</issn>
      <issn pub-type="epub">1496-8975</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3033524</article-id>
      <article-id pub-id-type="pmid">21194017</article-id>
      <article-id pub-id-type="publisher-id">9429</article-id>
      <article-id pub-id-type="doi">10.1007/s12630-010-9429-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Theme Issue: Mechanisms of Anesthesia</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>GABA<sub>A</sub> receptors as molecular targets of general anesthetics: identification of binding sites provides clues to allosteric modulation</article-title>
        <trans-title-group>
          <trans-title xml:lang="fr">Les r&#xE9;cepteurs GABA<sub>A</sub> comme cibles mol&#xE9;culaires des anesth&#xE9;siques g&#xE9;n&#xE9;raux: l&#x2019;identification des sites de liaison procure des pistes pour comprendre la modulation allost&#xE9;rique</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Olsen</surname>
            <given-names>Richard W.</given-names>
          </name>
          <degrees>PhD</degrees>
          <address>
            <email>rolsen@mednet.ucla.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Guo-Dong</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Molecular &amp; Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Room CHS 23-120, 650 Young Drive South, Los Angeles, CA 90095-1735 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>31</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <volume>58</volume>
      <issue>2</issue>
      <fpage>206</fpage>
      <lpage>215</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>11</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>The purpose of this review is to summarize current knowledge of detailed biochemical evidence for the role of &#x3B3;-aminobutyric acid type A receptors (GABA<sub>A</sub>&#x2013;Rs) in the mechanisms of general anesthesia.</p>
        </sec>
        <sec>
          <title>Principal findings</title>
          <p>With the knowledge that all general anesthetics positively modulate GABA<sub>A</sub>-R-mediated inhibitory transmission, site-directed mutagenesis comparing sequences of GABA<sub>A</sub>-R subunits of varying sensitivity led to identification of amino acid residues in the transmembrane domain that are critical for the drug actions <italic>in vitro</italic>. Using a photo incorporable analogue of the general anesthetic, R(+)etomidate, we identified two transmembrane amino acids that were affinity labelled in purified bovine brain GABA<sub>A</sub>-R. Homology protein structural modelling positions these two residues, &#x3B1;M1-11&#x2019; and &#x3B2;M3-4&#x2019;, close to each other in a single type of intersubunit etomidate binding pocket at the &#x3B2;/&#x3B1; interface. This position would be appropriate for modulation of agonist channel gating. Overall, available information suggests that these two etomidate binding residues are allosterically coupled to sites of action of steroids, barbiturates, volatile agents, and propofol, but not alcohols. Residue &#x3B1;/&#x3B2;M2-15&#x2019; is probably not a binding site but allosterically coupled to action of volatile agents, alcohols, and intravenous agents, and &#x3B1;/&#x3B2;M1-(-2&#x2019;) is coupled to action of intravenous agents.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Establishment of a coherent and consistent structural model of the GABA<sub>A</sub>-R lends support to the conclusion that general anesthetics can modulate function by binding to appropriate domains on the protein. Genetic engineering of mice with mutation in some of these GABA<sub>A</sub>-R residues are insensitive to general anesthetics <italic>in vivo</italic>, suggesting that further analysis of these domains could lead to development of more potent and specific drugs.</p>
        </sec>
      </abstract>
      <trans-abstract xml:lang="fr">
        <title>R&#xE9;sum&#xE9;</title>
        <sec>
          <title>Objectif</title>
          <p>L&#x2019;objectif de cet article de synth&#xE8;se est de r&#xE9;sumer les connaissances actuelles concernant les donn&#xE9;es probantes biochimiques d&#xE9;taill&#xE9;es &#xE9;lucidant le r&#xF4;le des r&#xE9;cepteurs &#xE0; l&#x2019;acide &#x3B3;-aminobutyrique de type A (R-GABA<sub>A</sub>) dans les m&#xE9;canismes de l&#x2019;anesth&#xE9;sie g&#xE9;n&#xE9;rale.</p>
        </sec>
        <sec>
          <title>Constatations principales</title>
          <p>Tous les anesth&#xE9;siques g&#xE9;n&#xE9;raux modulent positivement la transmission inhibitrice m&#xE9;di&#xE9;e par les R-GABA<sub>A</sub>. On a identifi&#xE9; les acides amin&#xE9;s du domaine transmembranaire repr&#xE9;sentant des sites d&#x2019;action importants des m&#xE9;dicaments, en effectuant des mutations cibl&#xE9;es sur des s&#xE9;quences de sous-unit&#xE9;s des R-GABA<sub>A</sub> et en comparant leur sensibilit&#xE9;. &#xC0; l&#x2019;aide d&#x2019;un analogue photo luminescent de l&#x2019;anesth&#xE9;sique g&#xE9;n&#xE9;ral &#xE9;tomidate R(+), nous avons identifi&#xE9; deux acides amin&#xE9;s transmembranaires marqu&#xE9;es par affinit&#xE9; dans les R-GABA<sub>A</sub> purifi&#xE9;s de cerveau bovin. Un mod&#xE8;le structurel de prot&#xE9;ine par homologie place ces deux r&#xE9;sidus, soit &#x3B1;M1-11&#x2019; et &#x3B2;M3-4&#x2019;, &#xE0; proximit&#xE9; l&#x2019;un de l&#x2019;autre dans un type unique de poche de liaison d&#x2019;&#xE9;tomidate inter-sous-unit&#xE9; au niveau de l&#x2019;interface &#x3B2;/&#x3B1;. Cette position sera adapt&#xE9;e pour moduler le portillon des canaux agonistes. Globalement, les donn&#xE9;es disponibles sugg&#xE8;rent que des deux r&#xE9;sidus se liant &#xE0; l&#x2019;&#xE9;tomidate sont coupl&#xE9;s de fa&#xE7;on allost&#xE9;rique aux sites d&#x2019;action des st&#xE9;ro&#xEF;des, des barbituriques, des agents volatils et du propofol, mais pas &#xE0; ceux des alcools. Le r&#xE9;sidu &#x3B1;/&#x3B2;M2-15&#x2019; n&#x2019;est probablement pas un site de liaison, mais il est coupl&#xE9; de fa&#xE7;on allost&#xE9;rique &#xE0; l&#x2019;action des agents volatils, des alcools et des agents intraveineux, et le &#x3B1;/&#x3B2;M1-(-2&#x2019;) est coupl&#xE9; &#xE0; l&#x2019;action des agents intraveineux.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>La cr&#xE9;ation d&#x2019;un mod&#xE8;le structurel coh&#xE9;rent et logique des R-GABA<sub>A</sub> appuie notre conclusion selon laquelle les anesth&#xE9;siques g&#xE9;n&#xE9;raux peuvent moduler leur fonction en se liant &#xE0; des domaines sp&#xE9;cifiques sur la prot&#xE9;ine. Les souris g&#xE9;n&#xE9;tiquement modifi&#xE9;es porteuses d&#x2019;une mutation dans certains de ces r&#xE9;sidus de R-GABA<sub>A</sub> ne sont pas sensibles aux anesth&#xE9;siques g&#xE9;n&#xE9;raux <italic>in vivo</italic>, ce qui sugg&#xE8;re qu&#x2019;une analyse plus approfondie de ces domaines pourrait permettre la mise au point de m&#xE9;dicaments &#xE0; la fois plus puissants et plus sp&#xE9;cifiques.</p>
        </sec>
      </trans-abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Canadian Anesthesiologists' Society 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>The purpose of this review is to inform the reader of the current knowledge of detailed biochemical evidence for the role of &#x3B3;-aminobutyric acid type A receptors (GABA<sub>A</sub>&#x2013;Rs) in the mechanisms of anesthesia. We briefly summarize the evidence connecting anesthetic action on the brain with action on GABA<sub>A</sub>-Rs and the structure and function of GABA<sub>A</sub>-Rs. We describe the major techniques utilized for determination of amino acids and sequence domains within proteins that participate in various functions, and we summarize the newest data developed on the study of GABA<sub>A</sub>-Rs to identify such sites. We also discuss how the overall data for all the chemical classes of general anesthetics either form or do not form a coherent story for a role for GABA<sub>A</sub>-Rs in anesthetic action and its relevance for the future of clinical anesthesiology.</p>
    <p>Most drugs that act as general anesthetics act only at relatively high concentrations, and their interaction with biosystems has long been considered as more of a physical interaction, namely, perturbation of fluidity of the membrane lipid bilayer, which is consistent with the Meyer-Overton correlation. In this correlation, potency as a general anesthetic is directly related to the solubility ratio for the compound in an oil-water mixture rather than to chemically specific binding to recognition sites on the molecules involved, as in traditional drug receptors.<xref ref-type="bibr" rid="CR1">1</xref> However, recent electrophysiological studies on specificity of action of anesthetic agents on biosystems and biochemical investigations on specific interactions with proteins, especially membrane channels, suggest that general anesthetics probably act via hydrophobic regions of protein targets in neurons.<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref> A major candidate for the target of general anesthetics is the GABA<sub>A</sub> receptor, a ligand-gated chloride ion channel receptor for the neurotransmitter GABA, which universally inhibits neuronal excitability via synaptic phasic currents as well as extrasynaptic tonic currents.<xref ref-type="bibr" rid="CR4">4</xref>-<xref ref-type="bibr" rid="CR7">7</xref> The GABA<sub>A</sub> -Rs are actually a family of heteropentamers with differing subunit composition that vary in their age-dependence and brain and subcellular localization of expression and trafficking, as well as their pharmacological specificity, including sensitivity to GABA agonists and allosteric modulators, such as benzodiazepines, general anesthetics, neurosteroids, and ethanol (EtOH).<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></p>
    <sec id="Sec1">
      <title>General anesthetic action and GABA<sub>A</sub>-Rs</title>
      <p>Most if not all general anesthetics at relevant concentrations enhance the function of GABA<sub>A</sub>-Rs, and GABA<sub>A</sub>-Rs are positioned in the nervous system where they can mediate anesthesia.<xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR10">10</xref>-<xref ref-type="bibr" rid="CR12">12</xref> People have used the differential sensitivity of GABA<sub>A</sub>-R subunits to anesthetic modulation, especially the low sensitivity of &#x3C1; subtypes, to attempt to identify amino acid residues in the GABA<sub>A</sub>-R subunit sequences that are critical for anesthetic modulation.<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref> The residues implicated are in or near the transmembrane domains. Virtually all of the chemical classes of adrugs with general anesthetic activity are implicated, including especially all of the intravenously administered agents, such as, etomidate, propofol, barbiturates, steroids, and alcohols, as well as the volatile gaseous agents. Some of these transmembrane GABA<sub>A</sub>-R residues have been mutated in knock-in mice, which subsequently lose sensitivity to general anesthetics, thus verifying the important role of GABA<sub>A</sub>-Rs in anesthetic action.<xref ref-type="bibr" rid="CR12">12</xref></p>
    </sec>
    <sec id="Sec2">
      <title>Alcohol action and GABA<sub>A</sub>-Rs</title>
      <p>Ethanol does enhance GABA<sub>A</sub>-Rs and glycine receptors, much like longer chain alcohols (e.g., <italic>n</italic>-octanol), but at very high (anesthetic) concentrations. We need to distinguish between these <italic>anesthetic</italic> effects of high-dose EtOH and longer chain alcohols and the intoxicating effects of lower doses, such as those encountered in the human brain during social drinking, because evidence suggests that effects of low- and high-dose EtOH involve (at least) two distinct targets in the brain. We suggest that these receptors that are sensitive to EtOH levels resulting from one glass of wine (3-30&#xA0;mM) are certain subtypes of GABA<sub>A</sub>-R, the &#x3B4; subunit-containing extrasynaptic GABA<sub>A</sub>-R that mediate tonic inhibition.<xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref> One major target of anesthetic doses of EtOH (30-100&#xA0;mM) is in the transmembrane domain of GABA<sub>A</sub>-Rs and glycine receptors.<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></p>
      <p>Evidence suggests that EtOH has a second site of interaction with GABA<sub>A</sub>-R that is relevant to its pharmacological actions at low doses as produced in humans by one glass of wine.<xref ref-type="bibr" rid="CR16">16</xref> Studies on a naturally-occurring allele in the rat GABA<sub>A</sub>-R &#x3B1;6 subunit suggests that the residue, &#x3B1;4/6R100, is involved in EtOH action as well as its blockade by the benzodiazepine ligand, Ro15-4513.<xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref> These results are consistent with our observations that the &#x3B1;4/6&#x3B2;3&#x3B4; subtypes of GABA<sub>A</sub>-R are more sensitive to EtOH (low mM) than other subtypes, including the &#x3B3;2 subunit or the &#x3B2;1/2 subunits.<xref ref-type="bibr" rid="CR15">15</xref> Moreover, this is consistent with the observation by many that EtOH at low mM concentrations enhances GABA<sub>A</sub>-R-mediated tonic inhibitory currents in cells expressing the &#x3B4; GABA<sub>A</sub>-R subunit.<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR21">21</xref>-<xref ref-type="bibr" rid="CR23">23</xref> This hypothesis remains controversial,<xref ref-type="bibr" rid="CR24">24</xref> as the expression of recombinant &#x3B4; subunits is very difficult and thus hardly studied, and the brain slice/neuron work is still in its infancy; however, we believe the hypothesis will be accepted as it becomes better understood. Our preliminary investigations of domains within the &#x3B2;3 and &#x3B4; subunits that interact in &#x3B1;4/6&#x3B2;3&#x3B4; subtypes implicate residues in the &#x3B2;3 subunit that are homologous to the benzodiazepine binding site involving &#x3B1;R100, which produces an EtOH-sensitive binding site for certain benzodiazepines, like Ro15-4513, that would be located at the &#x3B1;+/&#x3B2;- interface in the extracellular domain. Future work will determine whether this model has any basis in reality.</p>
    </sec>
    <sec id="Sec3">
      <title>Methods for identification of amino acids involved in specific functions of proteins, including allosteric modulators</title>
      <sec id="Sec4">
        <title>Chimeras and site-directed mutagenesis</title>
        <p>An often utilized and frequently successful technique is to compare polypeptide sequences of homologous subunits showing varying sensitivity to drugs. For example, Mihic <italic>et al</italic>.<xref ref-type="bibr" rid="CR13">13</xref> compared glycine receptors (sensitive to isoflurane and high-dose EtOH) with GABA<sub>A</sub>-R &#x3C1; subunits (insensitive to these modulators). One makes chimeric cDNAs that differ in the domain of interest and determine which residues are critical. This is followed by site-directed point mutations in suspected residues until the critical one(s) is identified. On the negative side, identification of residues that determine modulatory drug sensitivity by mutagenesis alone may be allosterically coupled to the function rather than involved in binding <italic>per se</italic>. Thus, the initial observation requires confirmation by secondary approaches. This could involve studying a number of mutations for the implicated residue to discover the shape and properties the &#x201C;pocket&#x201D; might show, or attempting a covalent couple of an analogue of the anesthetic containing a sulfhydryl reagent to the cysteine-substituted candidate residue.<xref ref-type="bibr" rid="CR25">25</xref>-<xref ref-type="bibr" rid="CR27">27</xref></p>
      </sec>
      <sec id="Sec5">
        <title>Affinity labelling</title>
        <p>The use of affinity labels is more likely to identify residues involved in a binding pocket, because the ligand has to have reasonable affinity for the target protein and a chemical group that will bind the protein covalently. The ligand will label residues in close contact when it is bound to the receptor. To maximize specificity, the chemically reactive group is often stable until chemically activated, e.g., by ultraviolet light.<xref ref-type="bibr" rid="CR28">28</xref> Nevertheless, some uncertainty arises from possible movement of the activated ligand from the binding site to nearby areas, depending on its lifetime and relative reactivity. Thus, additional evidence consistent with identification of the labelled residues as binding site constituents is also useful here. Making the affinity label radioactive can allow identification of the subunit polypeptide-carrying binding sites on SDS gels and can aid in sequencing the peptide. This binding must be prevented by excess non-radioactive ligand, and its relevance to the drug receptor can be supported by evidence of allosteric modulation of its binding by other receptor ligands. Another advantage of affinity labelling is the fact that the results are unbiased by having to guess in advance which residues might be important, as required with mutagenesis. We succeeded in using this technique for anesthetic binding to GABA<sub>A</sub>-R.<xref ref-type="bibr" rid="CR29">29</xref></p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Major findings</title>
      <sec id="Sec7">
        <title>Site-directed mutagenesis results</title>
        <p>Wingrove <italic>et al</italic>. (1994)<xref ref-type="bibr" rid="CR30">30</xref> found that modulation of GABAR by the anticonvulsant/anxiolytic loreclezole depended on the nature of the &#x3B2; subunit (&#x3B2;2/&#x3B2;3 &#x226B; &#x3B2;1). Belelli <italic>et al</italic>. (1997)<xref ref-type="bibr" rid="CR31">31</xref> extended this &#x3B2; subunit selectivity to the intravenous anesthetic, etomidate, a chemical analogue of loreclezole, and demonstrated that the &#x3B2; selectivity was due to residue 265, which is N in both &#x3B2;2 and &#x3B2;3 (sensitive to etomidate) and differed from &#x3B2;1 (S, insensitive to etomidate) as well as the insect &#x3B2; (Rdl, which has M, insensitive to etomidate). They<xref ref-type="bibr" rid="CR31">31</xref> showed that a single amino acid in GABA<sub>A</sub>-R, &#x3B2;2N265, (&#x3B2;M2-15&#x2019;) was responsible for the selectivity of &#x3B2;2 and &#x3B2;3 over &#x3B2;1 for the modulatory drugs, loreclezole and etomidate. This &#x3B2; selectivity was found to extend to the related intravenous anesthetic, propofol.<xref ref-type="bibr" rid="CR32">32</xref></p>
        <p>Mihic <italic>et al</italic>. (1997)<xref ref-type="bibr" rid="CR13">13</xref> used the anesthetic-insensitive GABA<sub>A</sub>-R &#x3C1; subunit sequence and the anesthetic-sensitive glycine receptor &#x3B1; and GABAR &#x3B1; and &#x3B2; subunits to identify, by construction of chimeras and point mutations, some amino acid residues critical for modulation of GlyR and GABA<sub>A</sub>-R by volatile anesthetics and long-chain alcohols, implicating the M2-15&#x2019; and M3-4&#x2019; residues in both the &#x3B1; and &#x3B2; subunits of GABA<sub>A</sub>-R. Note that the M2-15&#x2019; residue is the same as the one found simultaneously by Belelli <italic>et al.</italic> (1997).<xref ref-type="bibr" rid="CR31">31</xref></p>
        <p>Carlson <italic>et al.</italic> (2000)<xref ref-type="bibr" rid="CR14">14</xref> took a similar approach to identify a single amino acid at the entrance to M1(-2&#x2019;) in GABA<sub>A</sub>-R &#x3B1; and &#x3B2;, i.e., &#x3B2;2G229, which when mutated to larger (e.g., F as in &#x3C1;) or charged residues gave significantly reduced sensitivity to modulation of binding and function by steroids, etomidate, propofol, and barbiturates, with enhanced direct gating by these drugs. Thus, it appeared that larger than normal amino acids at this position took the place of anesthetics in partially enhancing GABA, so that the extent of enhancement by the exogenous anesthetic ligand was reduced.</p>
        <p>In addition to the residues identified by Mihic <italic>et al.</italic> (1997)<xref ref-type="bibr" rid="CR13">13</xref> for anesthetic doses of EtOH enhancement of glycine receptors (transmembrane &#x3B1;1S267[M2-15&#x2019;]), Daryl Davies and Ron Alkana found that residues in the extracellular domain loop 2 (&#x3B1;1A52) are also needed<xref ref-type="bibr" rid="CR33">33</xref> and proposed to be in the same pocket as M2-15&#x2019;. These workers also went on to show that modification of loop 2 in glycine receptor &#x3B1;1 subunits or in GABA<sub>A</sub>-R &#x3B3;2 subunit, such as replacement by the loop 2 10-residue peptide fragment from the GABA<sub>A</sub>-R &#x3B4; subunit, increases EtOH sensitivity about tenfold, as measured in oocyte recordings.<xref ref-type="bibr" rid="CR34">34</xref></p>
        <p>Hosie <italic>et al.</italic> (2006)<xref ref-type="bibr" rid="CR35">35</xref> constructed chimeras replacing steroid-sensitive &#x3B1;1 and &#x3B2;2 subunits of the GABA<sub>A</sub>-R M1 &#x2013; M2 residues with those from the steroid-insensitive insect Rdl clone; this reduced steroid modulation, potentiation of GABA, and direct activation of &#x3B1;&#x3B2;&#x3B3; receptors when &#x3B1;1 was mutated, but not &#x3B2;2. Steroid modulation was shown to depend on the nature of several residues in the transmembrane helix. They provided evidence that &#x3B1;1Q242(M1-10&#x2019;) and &#x3B1;1N408 and Y411 in M4 (bovine numbering)<xref ref-type="bibr" rid="CR36">36</xref> could provide anchor points to bind the two ends of the steroid molecule. Also, &#x3B1;1T237(M1-5&#x2019;) (bovine numbering) and &#x3B2;Y284 were shown to be essential for direct activation, and protein structural modelling suggested that they were located near each other in a single intersubunit pocket at the &#x3B2;M3-&#x3B1;M1 interface.<xref ref-type="bibr" rid="CR35">35</xref> This possible model is discussed further below.</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Mouse knock-ins</title>
      <p>The results of Belelli <italic>et al</italic>. (1997)<xref ref-type="bibr" rid="CR31">31</xref> led to the production of knock-in mice with point mutations in this single GABA<sub>A</sub>-R subunit &#x3B2;M2-15&#x2019; residue. Both the &#x3B2;2N265S (replaced with the &#x3B2;1 residue),<xref ref-type="bibr" rid="CR37">37</xref> which showed less sensitivity to the sedative action of etomidate, and the &#x3B2;3N265&#xA0;M (replaced with the anesthetic-insensitive insect residue),<xref ref-type="bibr" rid="CR38">38</xref> which showed less sensitivity to the immobilization action of etomidate and propofol, provided strong evidence for the role of GABA<sub>A</sub>-Rs in anesthetic action. Furthermore, a subunit composition-dependent pharmacology was established, presumably due to an anatomical correlate of anesthetic sensitivity. In other words, the &#x3B2;3-containing GABA<sub>A</sub>-Rs and the circuits in which they function are involved in the anesthetic actions of etomidate, while the &#x3B2;2-containing GABA<sub>A</sub>-Rs are not but are involved in some of the sedative and other actions of etomidate; &#x3B2;1-containing GABA<sub>A</sub>-Rs are not involved in anesthetic actions of etomidate.<xref ref-type="bibr" rid="CR12">12</xref></p>
      <p>Harrison <italic>et al.</italic> went on to test the &#x3B1;1S270H mutation in knock-in mice for reduced sensitivity to anesthetics. Hall <italic>et al</italic>. (2004)<xref ref-type="bibr" rid="CR39">39</xref> found a reduced sensitivity to isoflurane in enhancing GABA<sub>A</sub>-R current, with increased probability of opening for the mutant channels in absence of anesthetic. Elsen <italic>et al</italic>. (2006)<xref ref-type="bibr" rid="CR40">40</xref> found altered responses to volatile anesthetics <italic>in vivo</italic>, including reduced time of anesthesia and abnormal seizure-like behaviours on coming out of anesthesia. This is not strong evidence for an anesthetic site of action. However, the &#x3B1;1S270H (M2-15&#x2019;) knock-in mice had a sickly phenotype, interpreted as likely due to the left-shift in the GABA dose-response curve and a corresponding excessive GABAergic inhibition <italic>in vivo</italic>.<xref ref-type="bibr" rid="CR39">39</xref> A compensatory second knock-in point mutation, &#x3B1;1L277A, introduced into the S270H mouse restored normal neuronal and <italic>in vivo</italic> excitability levels, normal GABA sensitivity, and normal health<xref ref-type="bibr" rid="CR41">41</xref> and allowed demonstration that these animals exhibited less than normal responses in some assays of volatile anesthetic<xref ref-type="bibr" rid="CR42">42</xref> and high (anesthetic)- dose EtOH effects.<xref ref-type="bibr" rid="CR43">43</xref></p>
    </sec>
    <sec id="Sec9">
      <title>Affinity labelling with azietomidate</title>
      <p>We have used the technique of photoaffinity labelling, synthesizing a photo-incorporable analogue of etomidate with anesthetic efficacy, R(+)azietomidate, and then radiolabelling it.<xref ref-type="bibr" rid="CR44">44</xref> This ligand [<sup>3</sup>H]azietomidate was successfully employed to photolabel benzodiazepine affinity-purified GABA<sub>A</sub>-R proteins from cow brain and identify two amino acids as sites of attachment.<xref ref-type="bibr" rid="CR29">29</xref> The team led by Keith Miller at Massachusetts General Hospital synthesized a photo-incorporable anesthetic, R(+)azietomidate, a close analogue of etomidate, and demonstrated both bio-activity as well as photoaffinity labelling capability.<xref ref-type="bibr" rid="CR44">44</xref> Using detergent-solubilized membranes that retained the allosteric modulation of GABA<sub>A</sub>-R radioligand binding by etomidate, the Richard Olsen lab purified to homogeneity the GABA<sub>A</sub>-R protein from bovine cerebral cortex and photoaffinity labelled the pooled protein (several hundred pmol) with [<sup>3</sup>H]azietomidate, leading to a single peak of radioactive protein at ca. 55&#xA0;kDa, which was shown by mass spectrometry and Western blotting to contain GABA<sub>A</sub>-R &#x3B1;1, &#x3B1;2, &#x3B1;3, &#x3B1;5, &#x3B2;1, &#x3B2;2, &#x3B2;3, and &#x3B3;2 (and a trace of &#x3B1;4) subunits. Edman degradation microsequencing of proteolytic fragments purified on high performance liquid chromotogrpahy (HPLC) by the Jon Cohen lab allowed identification of the labelled amino acids. The residues that were labelled do not appear to be nonspecifically tagged. The same results have now been obtained on numerous occasions; alkyl azides are not particularly reactive with Met residues, and several more reactive residues as well as two other methionines in the region near our two identified amino acids were not reactive.</p>
      <p>The residues labelled were M236 in the M1 domain of the alpha subunits (&#x3B1;1, 2, 3, and 5 were all the same in the relevant peptides) and M286 in the M3 domain of the beta subunits (also identical in &#x3B2;1, 2, and 3). The attachment sites for etomidate were thus identified as &#x3B1;M1-11&#x2019; (M236) and &#x3B2;M3-4&#x2019; (M286) (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<xref ref-type="bibr" rid="CR29">29</xref> The latter is the same as one of the two identified by Mihic <italic>et al.</italic> for anesthetic alcohols and volatile agents.<xref ref-type="bibr" rid="CR13">13</xref> The former had not been described previously for anesthetic interactions. Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref> shows a 3-D model of the heteropentameric GABA<sub>A</sub>-R with the GABA and BZ sites at subunit interfaces in the extracellular domain and etomidate sites in the transmembrane domain.<xref ref-type="bibr" rid="CR29">29</xref> The BZ sites are modified GABA sites located at a different subunit interface, that is, homologous residues corresponding to agonist binding pocket loops in the protein at the two &#x3B2;/&#x3B1; interfaces for GABA binding are involved in BZ binding at the single &#x3B1;/&#x3B3; interface.<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR45">45</xref><table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Identified amino acids interacting with general anesthetics in GABA<sub>A</sub>-Rs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Residues<sup>*</sup></th><th align="left">&#x3B1;/&#x3B2; M1(-2&#x2019;)</th><th align="left">&#x3B1; M1(11&#x2019;)</th><th align="left">&#x3B1; M2(15&#x2019;)</th><th align="left">&#x3B2; M2(15&#x2019;)</th><th align="left">&#x3B2; M3 (4&#x2019;)</th></tr></thead><tbody><tr><td align="left">References</td><td align="left">14,54,55</td><td align="left">29,36,46</td><td align="left">13,25,26,39-43</td><td align="left">13,31,37,38,53</td><td align="left">29,36,46</td></tr><tr><td align="left">Etomidate</td><td align="left">+</td><td align="left">+</td><td align="left">&#x2021;</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left">Propofol</td><td align="left">+</td><td align="left">+</td><td align="left">&#x2021;</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left">Volatile agents, e.g., isoflurane</td><td align="left">&#x2021;</td><td align="left">+</td><td align="left">+</td><td align="left">&#x2021;</td><td align="left">+</td></tr><tr><td align="left">Steroids, e.g., alphaxalone</td><td align="left">+</td><td align="left">+</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">+</td></tr><tr><td align="left">Barbiturates</td><td align="left">+</td><td align="left">+</td><td align="left">&#x2021;</td><td align="left">&#x2021;</td><td align="left">+</td></tr><tr><td align="left">Alcohols</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">+</td><td align="left">+</td><td align="left">&#x2013;</td></tr><tr><td align="left">Knock-in&#x2020;</td><td align="left">&#x2021;</td><td align="left">&#x2021;</td><td align="left">+</td><td align="left">+</td><td align="left">&#x2021;</td></tr></tbody></table><table-wrap-foot><p>*Residues are identified by the convention for pentameric/cys-loop ligand-gated ion channel receptors designating the first amino acid in the transmembrane helix as 1&#x2019; and consecutively through the membrane. &#x2020; Knock-in refers to whether or not a knock-in mouse for this residue has been generated and shows evidence consistent with a role in anesthetic action. A plus sign (+) signifies that the general anesthetic listed in rows at left of matrix is identified with the amino acid residue listed in columns at the top. A minus sign (&#x2212;) indicates that there is negative evidence for such an identification. The double dagger (&#x2021;) indicates that there is no conclusive evidence for or against; this includes topics that have not been determined. GABA<sub>A</sub>-Rs = gamma-aminobutyric acid type A receptors</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Three-dimensional views of the &#x3B3;-aminobutyric acid type A receptors (GABA<sub>A</sub>R) homology model from different perspectives (<bold>A,B</bold>) and helical wheel representation of the transmembrane regions at the etomidate binding domain at the &#x3B2;/&#x3B1; interface (<bold>C</bold>). <bold>A</bold>) Three-dimensional view of the GABA<sub>A</sub>R homology model (&#x3B2;3, cyan; &#x3B1;1, yellow; &#x3B3;2, green) from a perspective outside the membrane looking down the channel or <bold>B</bold>) from a perspective parallel to the membrane surface. Modified from Li <italic>et al</italic>. (2006)<xref ref-type="bibr" rid="CR29">29</xref> in which our homology model is based roughly on the nicotinic acetylcholine receptor cryo-EM derived structure (PDB:2BG9),<xref ref-type="bibr" rid="CR47">47</xref> modified by helical alignment data from Jansen &amp; Akabas (2006).<xref ref-type="bibr" rid="CR51">51</xref> Pockets in the vicinity of the etomidate (maroon), GABA (purple), and benzodiazepine (red) binding sites are shown as Connolly surfaces. <bold>C)</bold> Helical wheel representation of the GABA<sub>A</sub>R &#x3B2;/&#x3B1; interface in the trans-membrane domain illustrating the proposed binding site for etomidate (modified from Li <italic>et al</italic>., 2009).<xref ref-type="bibr" rid="CR36">36</xref> The model illustrates the orientation of residues from a homology model built on the nicotinic acetylcholine receptor cryo-EM derived structure,<xref ref-type="bibr" rid="CR47">47</xref> with the residues in &#x3B1;M1 and &#x3B2;M3 photolabelled by [<sup>3</sup>H]azietomidate (circled residues in <italic>green</italic>) contributing to a common binding pocket at the &#x3B2;/&#x3B1; interface. Also included: the position in &#x3B2;M2 (N265) that functions as a determinant of etomidate/azietomidate anesthetic potency <italic>in vivo</italic> (<italic>pink</italic>)<xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR62">62</xref>; the residues in &#x3B1;M1 and &#x3B2;M3 identified as sensitivity determinants for direct activation by neurosteroids (boxed residues in yellow)<xref ref-type="bibr" rid="CR35">35</xref>; and the positions in &#x3B1;M1 and &#x3B2;M3 that can form intersubunit cross-links when mutated to Cys (<italic>red</italic> and orange)<xref ref-type="bibr" rid="CR52">52</xref>,<xref ref-type="bibr" rid="CR58">58</xref></p></caption><graphic xlink:href="12630_2010_9429_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec10">
      <title>Interaction of other general anesthetics with azietomidate labelling sites</title>
      <p>The Table summarizes the studies with other chemical classes of general anesthetics. The intravenous agent, propofol, with a very similar pharmacological profile was able to inhibit the labelling of GABA<sub>A</sub>-R with azietomidate at anesthetic concentrations, but only partially, even when present in large excess over the etomidate. This partial inhibition was evident on both labelled residues, as shown by sequencing. The binding is not mutually exclusive, although it could involve overlapping sites. We conclude that it indicates an allosteric interaction.<xref ref-type="bibr" rid="CR46">46</xref> A similar partial inhibition was seen for a series of pharmacologically active barbiturates, also apparently allosteric.<xref ref-type="bibr" rid="CR46">46</xref> In addition, the anesthetic neurosteroids at appropriate concentrations did not inhibit azietomidate labelling but rather enhanced it. This proves that the steroid site does not coincide with the etomidate binding pocket and interacts allosterically.<xref ref-type="bibr" rid="CR36">36</xref> On the other hand, the volatile agent, isoflurane, showed a smooth inhibition curve down to zero and thus could possibly reflect competitive inhibition. However, the alcohols, <italic>n-</italic>octanol (10-1000&#xA0;&#x3BC;M) and EtOH (1-1000&#xA0;mM), failed to interact with azietomidate labelling, neither enhancing nor inhibiting.<xref ref-type="bibr" rid="CR46">46</xref> We have suggested another site for pharmacological actions of EtOH at low concentrations on GABA<sub>A</sub>-R.<xref ref-type="bibr" rid="CR16">16</xref></p>
    </sec>
    <sec id="Sec11">
      <title>Homology modelling</title>
      <p>Computer-enhanced electron microscope images of the <italic>Torpedo</italic> nicotinic acetylcholine receptor<xref ref-type="bibr" rid="CR47">47</xref> and the water-soluble acetylcholine binding protein<xref ref-type="bibr" rid="CR48">48</xref> allowed homology modelling of the GABA<sub>A</sub>-R and positioned the two etomidate labelled residues sufficiently close to each other (about 10 &#x1FA;) in the transmembrane domain to allow us to propose a single binding pocket at the interface between &#x3B1;M1 and &#x3B2;M3 (Li <italic>et al</italic>., 2006,<xref ref-type="bibr" rid="CR29">29</xref> Electronic Supplementary Material). This intersubunit etomidate binding pocket (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) would be present in two (identical) copies per pentamer at the same subunit interfaces (&#x3B2;+/&#x3B1;-) where GABA binding occurs in the extracellular domain. This seems a suitable position for allosteric modulation, especially relevant to the quaternary twist allosteric model for the pentameric ligand-gated ion channel receptors.<xref ref-type="bibr" rid="CR49">49</xref> The presence of only one kind of etomidate site<xref ref-type="bibr" rid="CR29">29</xref> suggests that both enhancement of GABA and direct gating by etomidate involve this one site. This is consistent with modelling of functional data following the Monod-Wyman-Changeux 2-state allosteric model.<xref ref-type="bibr" rid="CR50">50</xref><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>The intersubunit anesthetic binding pocket in the &#x3B3;-aminobutyric acid type A (GABA<sub>A</sub>) receptor transmembrane domain identified by photoaffinity labelling with [<sup>3</sup>H]azietomidate.<xref ref-type="bibr" rid="CR29">29</xref> The identified residue, M236, in the M1 domain of the &#x3B1; subunit is situated nearly adjacent to the identified residue, M286, in the M3 domain of the &#x3B2; subunit. Reproduced with permission from: <italic>Li GD, Chiara DC, Sawyer GW, Hussain SS, Olsen RW, Cohen JB</italic>. Identification of a GABA<sub>A</sub> receptor anesthetic binding site at subunit interfaces by photolabelling with an etomidate analog. J Neurosci 2006; 45: 11599-605</p></caption><graphic xlink:href="12630_2010_9429_Fig2_HTML" id="MO2"/></fig></p>
      <p>Jansen &amp; Akabas<xref ref-type="bibr" rid="CR51">51</xref> used &#x201C;cysteine scanning accessibility measurements&#x201D; and cross-linking to align the M2 and M3 helices of the nicotinic acetylcholine receptor and used homology GABA<sub>A</sub>R to allow a fixed setting of the helical wheels relevant to our proposed etomidate site.<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR36">36</xref> Bali <italic>et al</italic>.<xref ref-type="bibr" rid="CR52">52</xref> continued in this vein using cysteine substituents to align the M1 and M3 helices of GABA<sub>A</sub>R, refining the helical wheel orientations (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>C). This showed our two etomidate residues, &#x3B1;M1-11&#x2019; and &#x3B2;M3-4&#x2019;, to be very close and consistent with a single intersubunit anesthetic binding pocket at the &#x3B1;/&#x3B2; interface. One can also see that the &#x3B2;M2-15&#x2019; is not directly adjacent to the etomidate binding pocket but also is not very distant, and so it could possibly move into closer contact with &#x3B1;M1-11&#x2019; and &#x3B2;M3-4&#x2019;. On the other hand, the two residues implicated in steroid direct gating action<xref ref-type="bibr" rid="CR35">35</xref> (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>C) are on different sides of the helices and could not be part of a single binding pocket due to the distance between them. Those residues implicated in steroid enhancement of GABA are not shown on this helix but would not overlap with the etomidate enhancement site we defined.</p>
    </sec>
    <sec id="Sec12">
      <title>Biochemistry and electrophysiological testing of models derived from residue identification and modelling</title>
      <p>Work in the lab of Harrison<xref ref-type="bibr" rid="CR25">25</xref> as a follow-up to Mihic <italic>et al</italic>.<xref ref-type="bibr" rid="CR13">13</xref> showed that the GABA<sub>A</sub>-R &#x3B1;M2-15&#x2019; involvement for volatiles was sensitive to the volume of the amino acid at that position, consistent with a binding pocket. Follow-up work in the lab of Harris<xref ref-type="bibr" rid="CR26">26</xref> showed that an alcohol sulfhydryl analogue, <italic>propane</italic>thiol, could be covalently attached to &#x3B1;M2-15&#x2019; when substituted by cysteine, leading to persistent enhancement of GABA responses. This was even more dramatically demonstrated for &#x3B2;2M2-15&#x2019;, which could be modified by the alcohol, <italic>octane</italic> methanethiosulfonate, when mutated to cysteine to produce a covalent attachment showing irreversible potentiation<xref ref-type="bibr" rid="CR53">53</xref> consistent with a long-chain alcohol binding site. The binding of the octanol analogue could be inhibited by <italic>n</italic>-octanol, and the modification was able to alter modulation of GABA function by butanol and isoflurane, with some reduction of modulation by alphaxalone and flunitrazepam, but not pentobarbital.<xref ref-type="bibr" rid="CR53">53</xref> Homology modelling in which GABA<sub>A</sub>-R transmembrane helices were aligned, as found in the nicotinic acetylcholine receptor,<xref ref-type="bibr" rid="CR47">47</xref> suggested that these two residues, &#x3B1; or &#x3B2; M2-15&#x2019; and M3-4&#x2019;, could be found in a single <italic>intrasubunit</italic> pocket.<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR18">18</xref> This supports the idea that the M2-15&#x2019; residue could be a binding site for long-chain alcohols and maybe volatile agents and could be sensitive to allosteric modulation by etomidate, propofol, and possibly other anesthetics. However, residues identified by mutagenesis alone could also be involved &#x201C;merely&#x201D; in allosteric transduction.</p>
      <p>Work in the lab of Olsen as follow-up to Carlson <italic>et al</italic>. (2000)<xref ref-type="bibr" rid="CR14">14</xref> found mutations at this M1 residue, &#x3B1; or &#x3B2;M1(-2&#x2019;), to alter rates of desensitization to GABA agonists and allosteric modulators.<xref ref-type="bibr" rid="CR54">54</xref> Mutations of &#x3B2;2M1(-2&#x2019;) to a series of residues differing in volume showed altered gating kinetics consistent with a binding pocket.<xref ref-type="bibr" rid="CR55">55</xref> These mutagenesis studies also showed distinctive effects on anesthetic direct gating <italic>vs</italic> enhancement of GABA, consistent with two separate sites of action. However, the lack of chemical specificity for the modulators involved is more consistent with an allosteric transduction site than a binding pocket.</p>
      <p>Mutagenesis analysis of the two etomidate binding residues of Li <italic>et al</italic>. (2006)<xref ref-type="bibr" rid="CR29">29</xref> has been studied by our lab<xref ref-type="bibr" rid="CR56">56</xref> and collaborator, Stu Forman. The first study replaced &#x3B1;M236 or &#x3B2;M286 with trp. Either mutation led to reduced allosteric modulation of GABA by etomidate, with increased spontaneous openings, GABA left-shift, and increased direct gating by etomidate,<xref ref-type="bibr" rid="CR57">57</xref> which we interpret as being consistent but not conclusive with the theory that the residues are in a binding pocket. The second study replaced the two etomidate residues with cysteine. With radioligand binding, we found that large but not small sulfhydryl reagents reacted with the &#x3B1;1M236 (M1-11&#x2019;) in a manner that irreversibly prevented etomidate modulation of GABA<sub>A</sub>-R ligand binding; furthermore, the reaction with the sulfhydryl reagents was protected by excess etomidate in the tube.<xref ref-type="bibr" rid="CR56">56</xref> Stewart &amp; Forman (2009)<xref ref-type="bibr" rid="CR58">58</xref> used electrophysiology with &#x3B1;1&#x3B2;2&#x3B3;2 GABA<sub>A</sub>-R to show that mutation &#x3B2;2M286C (M3-4&#x2019;) and &#x3B2;2N265C (M2-15&#x2019;) could react with the sulfhydryl reagent, <italic>p</italic>-Cl mercuribenzene sulfonate, to eliminate etomidate modulation of channel function, but that excess etomidate protected the M286 residue, but not the N265 residue, from reaction with the sulfhydryl reagent. This is consistent with the etomidate residues identified by affinity labelling as being part of an anesthetic binding pocket.</p>
    </sec>
    <sec id="Sec13">
      <title>Summary of residues in GABA<sub>A</sub>-Rs identified as necessary for anesthetic action</title>
      <p>Homology modelling with the data of Unwin<xref ref-type="bibr" rid="CR47">47</xref> as a template suggested that the two etomidate binding residues could be part of a single class (two copies per pentamer) of <italic>intersubunit</italic> binding pocket (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<xref ref-type="bibr" rid="CR29">29</xref> This is also consistent with a single site for etomidate direct gating and modulation of GABA current, as suggested by R&#xFC;sch <italic>et al</italic>. (2004).<xref ref-type="bibr" rid="CR50">50</xref> Crosslinking studies of cysteine-substituted helical residues in the Akabas lab<xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref> were totally consistent with this model, because residues that can crosslink between &#x3B1;M1 and &#x3B2;M3 position our etomidate residues, &#x3B1;M236 and &#x3B2;M286, nearly adjacent to each other (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>C).<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR36">36</xref> The transmembrane intersubunit pocket (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) appears well situated to allosterically modulate the quaternary twist conformational change produced to gate the channel after binding of agonist to its site in the same &#x3B2;/&#x3B1; subunit interface of the extracellular domain 50 &#x1FA; directly above (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Nevertheless, the general anesthetics, desflurane, halothane, and propofol, were shown to inhibit channel function<xref ref-type="bibr" rid="CR59">59</xref> of another pentameric ligand-gated ion channel, the bacterial GLIC channel,<xref ref-type="bibr" rid="CR60">60</xref> and binding of these anesthetics was shown in <italic>x-ray</italic> crystal structures to occur at <italic>intrasubunit</italic> pockets in the transmembrane domain (P-J Corringer, MAC2010 symposium).</p>
      <p>The intersubunit pocket between &#x3B2;M3 and &#x3B1;M1 for etomidate seems highly likely at this point. It remains unclear whether the other residue labelled by Mihic <italic>et al</italic>. (1997)<xref ref-type="bibr" rid="CR13">13</xref> at M2-15&#x2019; is part of this pocket. This residue was not affinity labelled by azietomidate. In our structural model, it is located sufficiently close to potentially participate in the binding pocket (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>C).<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR36">36</xref> Nevertheless, cysteine substitution of the three residues and inactivation by cysteine reagents revealed that etomidate occupancy was able to protect the cysteine reaction at &#x3B1;1M236C and &#x3B2;2M286C, but not at &#x3B2;2N265C, suggesting that the first two residues, but not the last, are in the etomidate binding pocket.<xref ref-type="bibr" rid="CR58">58</xref> This had been suggested earlier by Bali &amp; Akabas<xref ref-type="bibr" rid="CR61">61</xref> who showed that propofol occupancy could protect from cysteine reagent inactivation at &#x3B1;M286C, but not at &#x3B1;N265C. The M2-15&#x2019; residue is clearly very important for anesthetic action. If it is part of the intersubunit pocket (&#x3B1;M1/&#x3B2;M2/&#x3B2;M3), it is unlikely that it would also be part of an intrasubunit pocket (&#x3B1;M1/&#x3B1;M2/&#x3B1;M3 or &#x3B2;M1/&#x3B2;M2/&#x3B2;M3), but this remains to be seen. It could differ for the different chemical classes of general anesthetics. There is evidence<xref ref-type="bibr" rid="CR26">26</xref> that propanol can bind to the &#x3B1;M2-15&#x2019; and octanol<xref ref-type="bibr" rid="CR53">53</xref> can bind to the &#x3B2;M2-15&#x2019;, but these compounds do not interact with the etomidate binding residues, &#x3B1;M1-11&#x2019; and &#x3B2;M3-4&#x2019; (Li <italic>et al</italic>.).</p>
      <p>Hosie <italic>et al</italic>.<xref ref-type="bibr" rid="CR35">35</xref> identified residues in &#x3B1;M1 and &#x3B1;M4 needed for neurosteroid enhancement of GABA<sub>A</sub>-R and two residues in &#x3B1;M1 and &#x3B2;M3 needed for direct steroid gating, which were proposed to be part of a single intersubunit anesthetic steroid site. However, those two residues are not positioned near each other in the helical wheels generated by models of the intersubunit etomidate site consistent with the cysteine substitution cross-linking data<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR52">52</xref> and consistent with our demonstration that the GABA<sub>A</sub>-R steroid ligands do not inhibit azietomidate labelling but rather enhance the binding in a pharmacologically specific manner.<xref ref-type="bibr" rid="CR36">36</xref> Our study of additional chemical classes of general anesthetics (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) showed that propofol inhibited azietomidate labelling, but only partially, and thus probably allosterically.<xref ref-type="bibr" rid="CR46">46</xref> Likewise, barbiturates partially inhibited azietomidate labelling in a pharmacologically and stereo-specific manner, thus were probably allosteric. The volatile agent, isoflurane, gave a complete and possibly competitive inhibition of azietomidate labelling, while two alcohols, <italic>n</italic>-octanol and EtOH, at pharmacologically active concentrations gave no inhibition or enhancement of azietomidate labelling of brain GABA<sub>A</sub>-R.<xref ref-type="bibr" rid="CR46">46</xref> Taken together, the data on [<sup>3</sup>H]azietomidate labelling suggest that we have directly identified amino acids in the contact point and binding pocket for a general anesthetic in a relevant biological target of action, the GABA<sub>A</sub>-R protein in the mammalian brain. This information and future studies on the topic should provide a path to development of safer, more effective, and more selective general anesthetics.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p><bold>Conflicts of interest</bold> None declared.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campagna</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of actions of inhaled anesthetics</article-title>
          <source>N Engl J Med</source>
          <year>2003</year>
          <volume>348</volume>
          <fpage>2110</fpage>
          <lpage>2124</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMra021261</pub-id>
          <pub-id pub-id-type="pmid">12761368</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hemmings</surname>
              <given-names>HC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Akabas</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Trudell</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Orser</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>Emerging molecular mechanisms of general anesthetic action</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>503</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tips.2005.08.006</pub-id>
          <pub-id pub-id-type="pmid">16126282</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franks</surname>
              <given-names>NP</given-names>
            </name>
          </person-group>
          <article-title>General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal</article-title>
          <source>Nature Rev Neurosci</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>370</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn2372</pub-id>
          <pub-id pub-id-type="pmid">18425091</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macdonald</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>GABA<sub>A</sub> receptor channels</article-title>
          <source>Ann Rev Neurosci</source>
          <year>1994</year>
          <volume>17</volume>
          <fpage>569</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="pmid">7516126</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luddens</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Korpi</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Seeburg</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>GABA<sub>A</sub>/benzodiazepine receptor heterogeneity: neurophysiological implications</article-title>
          <source>Neuropharmacology</source>
          <year>1995</year>
          <volume>34</volume>
          <fpage>245</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="doi">10.1016/0028-3908(94)00158-O</pub-id>
          <pub-id pub-id-type="pmid">7630479</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mody</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pearce</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Diversity of inhibitory neurotransmission through GABA<sub>A</sub> receptors</article-title>
          <source>Trends Neurosci</source>
          <year>2004</year>
          <volume>27</volume>
          <fpage>569</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tins.2004.07.002</pub-id>
          <pub-id pub-id-type="pmid">15331240</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="other"><italic>Li G, Chang CS, Olsen RW.</italic> (2005) Anesthetic sites on GABA<sub>A</sub> receptors. <italic>In</italic>: Mashimo T, Ogli K, Uchida I (Eds). Basic and Systemic Mechanisms of Anesthesia. Amsterdam, Elsevier; Int Cong Ser 2005; 1283: 61-6.</mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Sieghart</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>International Union of Pharmacology LXX.. Subtypes of &#x3B3;-aminobutyric acid<sub>A</sub> receptors: classification on the basis of subunit composition, pharmacology, and function. Update</article-title>
          <source>Pharmacol Rev</source>
          <year>2008</year>
          <volume>60</volume>
          <fpage>243</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="doi">10.1124/pr.108.00505</pub-id>
          <pub-id pub-id-type="pmid">18790874</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacob</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Jurd</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>GABA<sub>A</sub> receptor trafficking and its role in the dynamic modulation of neuronal inhibition</article-title>
          <source>Nature Rev Neurosci</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>331</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn2370</pub-id>
          <pub-id pub-id-type="pmid">18382465</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Roth</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
          <article-title>Barbiturate enhancement of &#x3B3;-aminobutyric acid receptor binding and function as a mechanism of anesthesia</article-title>
          <source>Molecular and Cellular Mechanisms of Anesthetics</source>
          <year>1986</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Plenum Medical Book</publisher-name>
          <fpage>165</fpage>
          <lpage>177</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Sapp</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Bureau</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Kokka</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Allosteric actions of central nervous system depressants including anesthetics on subtypes of the inhibitory &#x3B3;-aminobutyric acid<sub>A</sub> receptor-chloride channel complex</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>1991</year>
          <volume>625</volume>
          <fpage>145</fpage>
          <lpage>154</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1749-6632.1991.tb33838.x</pub-id>
          <pub-id pub-id-type="pmid">1711804</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rudolph</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Antkowiak</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Molecular and neuronal substrates for general anaesthetics</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>709</fpage>
          <lpage>720</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn1496</pub-id>
          <pub-id pub-id-type="pmid">15322529</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mihic</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Wick</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sites of alcohol and volatile anaesthetic action on GABA<sub>A</sub> and glycine receptors</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>389</volume>
          <fpage>385</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="doi">10.1038/38738</pub-id>
          <pub-id pub-id-type="pmid">9311780</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlson</surname>
              <given-names>BX</given-names>
            </name>
            <name>
              <surname>Engblom</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Kristiansen</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schousboe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>A single glycine residue at the entrance to the first membrane-spanning domain of the &#x3B3;-aminobutyric acid type A receptor &#x3B2;2 subunit affects allosteric sensitivity to GABA and anesthetics</article-title>
          <source>Mol Pharmacol</source>
          <year>2000</year>
          <volume>57</volume>
          <fpage>474</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">10692487</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hanchar</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Ethanol enhances alpha 4/beta 3/delta and alpha 6/beta 3/delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>15218</fpage>
          <lpage>15223</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.2435171100</pub-id>
          <pub-id pub-id-type="pmid">14625373</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Hanchar</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Meera</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wallner</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>GABA<sub>A</sub> receptor subtypes: the &#x201C;one glass of wine&#x201D; receptors</article-title>
          <source>Alcohol</source>
          <year>2007</year>
          <volume>41</volume>
          <fpage>201</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="doi">10.1016/j.alcohol.2007.04.006</pub-id>
          <pub-id pub-id-type="pmid">17591543</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hanchar</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Low-dose alcohol actions on &#x3B1;4&#x3B2;3&#x3B4; GABA<sub>A</sub> receptors are reversed by the behavioral alcohol antagonist Ro15&#x2013;4513</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>8540</fpage>
          <lpage>8545</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0600194103</pub-id>
          <pub-id pub-id-type="pmid">16698930</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamakura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bertaccini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Trudell</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Anesthetics and ion channels: molecular models and sites of action</article-title>
          <source>Ann Rev Pharmacol Toxicol</source>
          <year>2001</year>
          <volume>41</volume>
          <fpage>23</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.41.1.23</pub-id>
          <pub-id pub-id-type="pmid">11264449</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanchar</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Dodson</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Otis</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Wallner</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Alcohol-induced motor impairment caused by increased extrasynaptic GABA<sub>A</sub> receptor activity. Nat</article-title>
          <source>Neurosci</source>
          <year>2005</year>
          <volume>8</volume>
          <fpage>339</fpage>
          <lpage>345</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanchar</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Chutsrinopkun</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Meera</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ethanol potently and competitively inhibits the binding of the alcohol antagonist Ro15&#x2013;4513 to &#x3B1;4/6&#x3B2;3&#x3B4; GABA<sub>A</sub> receptors</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>8546</fpage>
          <lpage>8551</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0509903103</pub-id>
          <pub-id pub-id-type="pmid">16581914</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Faria</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Mody</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Low ethanol concentrations selectively augment the tonic inhibition mediated by &#x3B4; subunit-containing GABA<sub>A</sub> receptors in hippocampal neurons</article-title>
          <source>J Neurosci</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>8379</fpage>
          <lpage>8382</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2040-04.2004</pub-id>
          <pub-id pub-id-type="pmid">15385620</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cagetti</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Houser</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Spigelman</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Chronic intermittent ethanol-induced switch of ethanol actions from extrasynaptic to synaptic hippocampal GABA<sub>A</sub> receptors</article-title>
          <source>J Neurosci</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>1749</fpage>
          <lpage>1758</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4702-05.2006</pub-id>
          <pub-id pub-id-type="pmid">16467523</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chandra</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Homanics</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>Ethanol modulates synaptic and extrasynaptic GABA<sub>A</sub> receptors in the thalamus</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2008</year>
          <volume>326</volume>
          <fpage>475</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.108.139303</pub-id>
          <pub-id pub-id-type="pmid">18477766</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lovinger</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Homanics</surname>
              <given-names>GE</given-names>
            </name>
          </person-group>
          <article-title>Tonic for what ails us? High-affinity GABA<sub>A</sub> receptors and alcohol</article-title>
          <source>Alcohol</source>
          <year>2007</year>
          <volume>41</volume>
          <fpage>139</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="doi">10.1016/j.alcohol.2007.03.008</pub-id>
          <pub-id pub-id-type="pmid">17521844</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jenkins</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Greenblatt</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Faulkner</surname>
              <given-names>HJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence for a common binding cavity for three general anesthetics within the GABA<sub>A</sub> receptor</article-title>
          <source>J Neurosci</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>RC136</fpage>
          <pub-id pub-id-type="pmid">11245705</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mascia</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Trudell</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Specific binding sites for alcohols and anesthetics on ligand-gated ion channels</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>9305</fpage>
          <lpage>9310</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.160128797</pub-id>
          <pub-id pub-id-type="pmid">10908659</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tan</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Gonthier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baur</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goeldner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sigel</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Proximity-accelerated chemical coupling reaction in the benzodiazepine-binding site of &#x3B3;-aminobutyric acid type A receptors: superposition of different allosteric modulators</article-title>
          <source>J Biol Chem</source>
          <year>2007</year>
          <volume>282</volume>
          <fpage>26316</fpage>
          <lpage>26325</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M702153200</pub-id>
          <pub-id pub-id-type="pmid">17626010</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kotzyba-Hibert</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kapfer</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Goeldner</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Recent trends in photoaffinity labeling</article-title>
          <source>Angew Chem Int Ed Engl</source>
          <year>1995</year>
          <volume>34</volume>
          <fpage>1296</fpage>
          <lpage>1312</lpage>
          <pub-id pub-id-type="doi">10.1002/anie.199512961</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Chiara</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Husain</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Identification of a GABA<sub>A</sub> receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog</article-title>
          <source>J Neurosci</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>11599</fpage>
          <lpage>11605</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3467-06.2006</pub-id>
          <pub-id pub-id-type="pmid">17093081</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wingrove</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Wafford</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Whiting</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>4569</fpage>
          <lpage>4573</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.91.10.4569</pub-id>
          <pub-id pub-id-type="pmid">8183949</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belelli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Wafford</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Whiting</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>The interaction of the general anesthetic etomidate with the <bold>&#x3B3;-</bold>aminobutyric acid type A receptor is influenced by a single amino acid</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>11031</fpage>
          <lpage>11036</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.94.20.11031</pub-id>
          <pub-id pub-id-type="pmid">9380754</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siegwart</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jurd</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Molecular determinants for the action of general anesthetics at recombinant &#x3B1;2&#x3B2;3&#x3B3;2 <bold>&#x3B3;-</bold>aminobutyric acid<sub>A</sub> receptors</article-title>
          <source>J Neurochem</source>
          <year>2002</year>
          <volume>80</volume>
          <fpage>140</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="doi">10.1046/j.0022-3042.2001.00682.x</pub-id>
          <pub-id pub-id-type="pmid">11796752</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crawford</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Trudell</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Bertaccini</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Alkana</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Evidence that ethanol acts on a target in Loop 2 of the extracellular domain of alpha1 glycine receptors</article-title>
          <source>J Neurochem</source>
          <year>2007</year>
          <volume>102</volume>
          <fpage>2097</fpage>
          <lpage>2109</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04680.x</pub-id>
          <pub-id pub-id-type="pmid">17561937</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perkins</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Trudell</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Asatryan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Alkana</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Loop 2 structure in glycine and GABA(A) receptors play a key role in determining ethanol sensitivity</article-title>
          <source>J Biol Chem</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>27304</fpage>
          <lpage>27314</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M109.023598</pub-id>
          <pub-id pub-id-type="pmid">19656948</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hosie</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Wilkins</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Smart</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <article-title>Endogenous neurosteroids regulate GABA<sub>A</sub> receptors through two discrete transmembrane sites</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>444</volume>
          <fpage>486</fpage>
          <lpage>489</lpage>
          <pub-id pub-id-type="doi">10.1038/nature05324</pub-id>
          <pub-id pub-id-type="pmid">17108970</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Chiara</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Neurosteroids allosterically modulate binding of the anesthetic etomidate to <bold>&#x3B3;-</bold>aminobutyric acid type A receptors</article-title>
          <source>J Biol Chem</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>11771</fpage>
          <lpage>11775</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.C900016200</pub-id>
          <pub-id pub-id-type="pmid">19282280</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reynolds</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Rosahl</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Cirone</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sedation and anesthesia mediated by distinct GABA<sub>A</sub> receptor isoforms</article-title>
          <source>J Neurosci</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>8608</fpage>
          <lpage>8617</lpage>
          <pub-id pub-id-type="pmid">13679430</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jurd</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Arras</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit</article-title>
          <source>FASEB J</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>250</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="pmid">12475885</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Rowan</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>RJN</given-names>
            </name>
            <name>
              <surname>Kelley</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>The effects of isoflurane on desensitized wild-type and &#x3B1;1(S270H) <bold>&#x3B3;-</bold>aminobutyric acid type A receptors</article-title>
          <source>Anesth Analg</source>
          <year>2004</year>
          <volume>98</volume>
          <fpage>1297</fpage>
          <lpage>1304</lpage>
          <pub-id pub-id-type="doi">10.1213/01.ANE.0000111108.78745.AD</pub-id>
          <pub-id pub-id-type="pmid">15105205</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elsen</surname>
              <given-names>FP</given-names>
            </name>
            <name>
              <surname>Liljelund</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Homanics</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>GABA<sub>A</sub>-R &#x3B1;1 subunit knockin mutation leads to abnormal EEG and anesthetic-induced seizure-like activity in mice</article-title>
          <source>Brain Res</source>
          <year>2006</year>
          <volume>1078</volume>
          <fpage>60</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2006.01.036</pub-id>
          <pub-id pub-id-type="pmid">16490182</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borghese</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Topf</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An isoflurane- and alcohol-insensitive mutant GABA<sub>A</sub> receptor alpha1 subunit with near normal affinity for GABA: characterization in heterologous systems and production of knock in mice</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2006</year>
          <volume>319</volume>
          <fpage>208</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.106.104406</pub-id>
          <pub-id pub-id-type="pmid">16807363</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <mixed-citation publication-type="other"><italic>Werner DF, Swihart A, Rau V, et al</italic>. Inhaled anesthetic responses of recombinant receptors and knockin mice harboring &#x3B1;2(S270H/L277A) GABA<sub>A</sub> receptor subunits that are resistant to isoflurane. J Pharmacol Exp Ther 2010; DOI: 10.1124/jpet.110.170431.</mixed-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Werner</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Blednov</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>Ariwodola</surname>
              <given-names>OJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Knockin mice with ethanol-insensitive alpha1-containing <bold>&#x3B3;-</bold>aminobutyric acid type A receptors display selective alterations in behavioral responses to ethanol</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2006</year>
          <volume>319</volume>
          <fpage>219</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.106.106161</pub-id>
          <pub-id pub-id-type="pmid">16785315</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Husain</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Ziebell</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Rusch</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels</article-title>
          <source>J Med Chem</source>
          <year>2003</year>
          <volume>46</volume>
          <fpage>1257</fpage>
          <lpage>1265</lpage>
          <pub-id pub-id-type="doi">10.1021/jm020465v</pub-id>
          <pub-id pub-id-type="pmid">12646036</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sigel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Buhr</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The benzodiazepine binding site of <bold>&#x3B3;-</bold>aminobutyric acid type A (GABA<sub>A</sub>) receptors</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>1997</year>
          <volume>18</volume>
          <fpage>425</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">9426470</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Chiara</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Numerous general anesthetics inhibit etomidate binding to GABA<sub>A</sub> receptors</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <fpage>8615</fpage>
          <lpage>8620</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M109.074708</pub-id>
          <pub-id pub-id-type="pmid">20083606</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Unwin</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Refined structure of the nicotinic acetylcholine receptor at 4A resolution</article-title>
          <source>J Mol Biol</source>
          <year>2005</year>
          <volume>346</volume>
          <fpage>967</fpage>
          <lpage>989</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2004.12.031</pub-id>
          <pub-id pub-id-type="pmid">15701510</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brejc</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dijk</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Klaassen</surname>
              <given-names>RV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors</article-title>
          <source>Nature</source>
          <year>2001</year>
          <volume>411</volume>
          <fpage>269</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1038/35077011</pub-id>
          <pub-id pub-id-type="pmid">11357122</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taly</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Corringer</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Grutter</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Implications of the quaternary twist allosteric model for the physiology and pathology of nicotinic acetylcholine receptors</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>16965</fpage>
          <lpage>16970</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0607477103</pub-id>
          <pub-id pub-id-type="pmid">17077146</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rusch</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Gating allosterism at a single class of etomidate sites on &#x3B1;1&#x3B2;2&#x3B3;2L GABA<sub>A</sub> receptors accounts for both direct activation and agonist modulation</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>20982</fpage>
          <lpage>20992</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M400472200</pub-id>
          <pub-id pub-id-type="pmid">15016806</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jansen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akabas</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>State-dependent cross-linking of the M2 and M3 segments: functional basis for the alignment of GABA<sub>A</sub> and acetylcholine receptor M3 segments</article-title>
          <source>J Neurosci</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>4492</fpage>
          <lpage>4499</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0224-06.2006</pub-id>
          <pub-id pub-id-type="pmid">16641228</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bali</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jansen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akabas</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>GABA-induced intersubunit conformational movement in the GABA<sub>A</sub> receptor &#x3B1;1M1-&#x3B2;2M3 transmembrane subunit interface: experimental basis for homology modeling of an intravenous anesthetic binding site</article-title>
          <source>J Neurosci</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>3083</fpage>
          <lpage>3092</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6090-08.2009</pub-id>
          <pub-id pub-id-type="pmid">19279245</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <mixed-citation publication-type="other"><italic>McCracken ML, Borghese CM, Trudell JR, Harris RA</italic>. A transmembrane amino acid in the GABA<sub>A</sub> receptor &#x3B2;2 subunit critical for the actions of alcohols and anesthetics. J Pharmacol Exp Ther 2010; DOI: 10.1124/jpet.110.170472.</mixed-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engblom</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>BX</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Schousboe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Christiansen</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Point mutation in the first transmembrane region of the &#x3B2;2 subunit of the <bold>&#x3B3;-</bold>aminobutyric acid type A receptor alters desensitization kinetics of <bold>&#x3B3;-</bold>aminobutyric acid and anesthetic-induced channel gating</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>17438</fpage>
          <lpage>17447</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M111215200</pub-id>
          <pub-id pub-id-type="pmid">11877425</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Olcese</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>A single M1 residue in the &#x3B2;2 subunit alters channel gating of GABA<sub>A</sub> receptor in anesthetic modulation and direct activation</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>42821</fpage>
          <lpage>42828</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M306978200</pub-id>
          <pub-id pub-id-type="pmid">12939268</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <mixed-citation publication-type="other"><italic>Li G, Olsen RW</italic>. A TM1 residue, &#x3B1;1M236, is important for a GABA<sub>A</sub> receptor anesthetic binding site. SfN 2007; 141.1 (abstract).</mixed-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Tryptophan mutations at azi- etomidate photo-incorporation sites on &#x3B1;1 or &#x3B2;2 subunits enhance GABA<sub>A</sub> receptor gating and reduce etomidate modulation</article-title>
          <source>Mol Pharmacol</source>
          <year>2008</year>
          <volume>74</volume>
          <fpage>1687</fpage>
          <lpage>1695</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.108.050500</pub-id>
          <pub-id pub-id-type="pmid">18805938</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <mixed-citation publication-type="other"><italic>Stewart D, Forman SA.</italic> Accessibility and etomidate protection of cysteine substitutions at azietomidate labeled residues in GABA<sub>A</sub> receptors. SfN 2009; 530.16 (abstract).</mixed-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Corringer</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Sonner</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Anesthetic sensitivity of the <italic>Gloeobacter violaceus</italic> proton-gated ion channel</article-title>
          <source>Anesth Analg</source>
          <year>2010</year>
          <volume>110</volume>
          <fpage>59</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1213/ANE.0b013e3181c4bc69</pub-id>
          <pub-id pub-id-type="pmid">19933531</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bocquet</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nury</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Baaden</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation</article-title>
          <source>Nature</source>
          <year>2009</year>
          <volume>457</volume>
          <fpage>111</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1038/nature07462</pub-id>
          <pub-id pub-id-type="pmid">18987633</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bali</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akabas</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Defining the propofol binding site location on the GABA<sub>A</sub> receptor</article-title>
          <source>Mol Pharmacol</source>
          <year>2004</year>
          <volume>65</volume>
          <fpage>68</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.65.1.68</pub-id>
          <pub-id pub-id-type="pmid">14722238</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liao</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sonner</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Husain</surname>
              <given-names>SS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>R(+) Etomidate and photoactivable R(+)azietomidate have comparable anesthetic activity in wild-type mice and comparably decreased activity in mice with a N265&#xA0;M point mutation in the gamma aminobutyric acid receptor &#x3B2;3 subunit</article-title>
          <source>Anesth Analg</source>
          <year>2005</year>
          <volume>101</volume>
          <fpage>131</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="doi">10.1213/01.ANE.0000153011.64764.6F</pub-id>
          <pub-id pub-id-type="pmid">15976219</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p>This article is accompanied by an editorial. Please see Can J Anesth 2011; 58(2).</p>
      </fn>
    </fn-group>
  </back>
</article>
